Form 4: Amgen SVP & CCO Nancy Grygiel Reports Changes in Beneficial Ownership

Nancy Grygiel, SVP & CCO of Amgen, reports changes in her beneficial ownership of Amgen stock, including acquisitions and holdings in a 401(k) plan.

Summary

• On March 6, 2024, Nancy Grygiel, SVP & CCO of Amgen, filed a Form 4 detailing changes in her beneficial ownership of Amgen stock.
• The report indicates the acquisition of 1,954 shares of common stock at $0, likely related to vesting of restricted stock units or dividend equivalents.
• Following the reported transaction, Grygiel directly owns 12,866 shares of Amgen common stock.
• She also indirectly owns 98.3725 shares through the company's 401(k) plan.
• The directly held shares include restricted stock units (RSUs) that will vest on various dates in the future, as well as dividend equivalents (DEs) that are credited on unvested RSUs.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral.

Positives

• The acquisition of shares could be interpreted as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the ownership stake of a key executive.

Key Dates